what's glp 1 GLP-1 Agonists: A Comprehensive Overview Frontiers | GLP-1 Receptor Agonists:

17,18 A post hoc analysis of LOOK AHEAD trial data found that participants who achieved at least a 10% body weight loss in the first year had a 21% lower rate of major adverse cardiac events

Ozempic (semaglutide) is a GLP-1 receptor agonist approved for type 2 diabetes

It imitates an intestinal hormone that stimulates insulin production, lowering your appetite and making you feel full

There is heterogeneity in data regarding insulin dose adjustments after initiating GLP-1 RA therapy

Achieving pharmacoequity will require a major shift in rapidly moving the research continuum from detecting and understanding the root causes of treatment disparities to developing and implementing multilevel evidence-based strategies to eliminate them